Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic, progressive condition where the primary treatment goal is to maintain control of glycated haemoglobin (HbA1c). In order for healthcare decision makers to ensure patients receive the highest standard of care within the available budget, the cl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Health Serv Res
Main Authors: Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., Postema, R., Townsend, R., Roudaut, M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635987/
https://ncbi.nlm.nih.gov/pubmed/26541516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-015-1139-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados